Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCG5 antisense RNA 1 (SCG5-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 15 (32,655,955-32,673,090 reverse strand)[5][7]. It is classified as an antisense RNA because it is transcribed from the DNA strand opposite to the sense (protein-coding) gene SCG5 (secretogranin V). Antisense RNAs like SCG5-AS1 are typically involved in regulating the expression of their corresponding sense genes, often by mechanisms such as RNA-RNA hybridization, which can impact mRNA stability and translation[9][3]. While antisense RNAs as a class are functionally significant in gene regulation and have potential therapeutic applications, there is currently no direct evidence that SCG5-AS1 itself serves as a drug target, biomarker, or is involved in disease, nor are there any known drugs targeting it specifically[1][5][7]. No safety or therapeutic information is available, and no clinical or experimental data link SCG5-AS1 to human diseases in the currently available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCG5 antisense RNA 1 (SCG5-AS1).